Geriatric Oncology Care in Brazil: Remote Geriatric Assessment-Driven Interventions With Supportive Care
Launched by CRISTIANE DECAT BERGEROT, PHD · Jul 16, 2025
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is a multicenter, randomized controlled trial evaluating the effectiveness of a telehealth-delivered, geriatric assessment-guided intervention (GAIN-S) in improving health outcomes for older adults with solid tumors who are initiating a new systemic cancer therapy (chemotherapy, immune checkpoint inhibitors, and/or tyrosine kinase inhibitors) in Brazil.
The intervention is adapted from the Geriatric Assessment and Intervention Network (GAIN) model and integrates multidisciplinary supportive care services delivered remotely. The study is conducted across 14 oncology practices, includin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 65 years or older at time of enrollment
- • Diagnosed with a solid tumor cancer of any stage
- • Scheduled to start a new systemic cancer therapy (chemotherapy, immune checkpoint inhibitors, and/or tyrosine kinase inhibitors)
- • Able to provide written informed consent
- • Physician approval for participation
- Exclusion Criteria:
- • Inability or unwillingness to comply with study procedures, including telehealth visits
- • Cognitive or other impairments precluding participation as determined by the investigator
- • Any condition that, in the investigator's opinion, would make the patient unsuitable for the study or interfere with study assessments
About Cristiane Decat Bergerot, Phd
Cristiane Decat Bergerot, PhD, is a dedicated clinical researcher specializing in [specify field if known, e.g., oncology, neurology]. With a strong academic background and extensive experience in clinical trial design and management, Dr. Bergerot is committed to advancing medical knowledge and improving patient outcomes through rigorous scientific investigation. As a clinical trial sponsor, she oversees the development and execution of studies aimed at evaluating innovative therapeutic interventions, ensuring adherence to ethical standards and regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rio De Janeiro, Rj, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported